Kuphuhliso olunomdla oluhlaziya intsimi yokhathalelo lwempilo, iyeza elitsha elikumgangatho ophezulu elaziwa ngokuba yiRaloxifene Hydrochloride lingene kwimarike, libonisa indlela yokutshintsha umdlalo wonyango kwiimeko ezahlukeneyo zempilo kunye nokuphucula kakhulu umgangatho wobomi.Eli candelo livelisa amayeza lifumene ukuqondwa ngokukhawuleza ngenxa yamandla alo amangalisayo ekujonganeni noluhlu lweenkxalabo zempilo.
Eyona nto imiselwe ukuthintela kunye nokunyangwa kwe-osteoporosis kubasetyhini be-postmenopausal, i-Raloxifene Hydrochloride ibonakalise ukuba iphumelele kakhulu ekunciphiseni ukulahleka kwethambo kunye nokuphucula ukuxinana kwamathambo amaminerali.I-Osteoporosis, imeko ebonakala ngokuncipha koxinzelelo lwamathambo, ibeka umngcipheko omkhulu wokwaphuka, ngakumbi kwabasetyhini abadala.Ngokusungulwa kwe-Raloxifene Hydrochloride, izigulane ngoku zifikelela kumlingane onamandla ekulweni nemiba enxulumene namathambo, ekugqibeleni ukunciphisa umngcipheko wokuphuka kunye nokuphucula impilo yethambo jikelele.
Nangona kunjalo, impembelelo yeRaloxifene Hydrochloride ifikelela kude ngaphaya kwonyango lwe-osteoporosis.Uphando lwakutsha nje luye lwatyhila amandla alo ekuthinteleni umhlaza webele ohlaselayo kubafazi be-postmenopausal abane-osteoporosis, kunye nokunciphisa umngcipheko wokuba nomhlaza webele we-estrogen receptor-positive.Oku kufunyaniswayo kuzisa ithemba elitsha kwizigulana nabasebenzi bezempilo ngokufanayo, kugxininisa ukubaluleka kwamayeza akumgangatho ophezulu ekuguquleni imeko yothintelo kunye nonyango lomhlaza wamabele.
Ngaphezu koko, indlela ekhethekileyo yeRaloxifene Hydrochloride inikezela ngezibonelelo ezongezelelweyo kwizigulane.Ngokungafaniyo nonyango lokubuyisela ihomoni yesiNtu, eli yeza alinazo iziphumo ezibi ezidla ngokunxulunyaniswa ne-estrogen, nto leyo eyenza ukuba ibe yeyona ndlela ikhuselekileyo.Ngaphaya koko, i-Raloxifene Hydrochloride ibonise isithembiso ekunyangeni ezinye iimeko zonyango ezifana ne-endometrial hyperplasia, isandulela somhlaza we-endometrial, kunye nokunciphisa umngcipheko weziganeko ze-cardiovascular kubafazi be-postmenopausal.
Ukuveliswa kwe-Raloxifene Hydrochloride ihambelana nemilinganiselo yokulawula umgangatho, iqinisekisa ukhuseleko kunye nokusebenza kwayo.Iinkampani ezixuba amayeza zityala imali eninzi kuphando nakuphuhliso, zisebenzisa itekhnoloji ephucukileyo kunye nemigaqo yovavanyo engqongqo ukugcina eyona migangatho iphezulu.Oku kuzibophelela okungagungqiyo kumgangatho kubaluleke kakhulu ekuboneleleni izigulane ngamayeza anamandla nathembekileyo anokuthembela kuwo, ekugqibeleni akhokelela kwiziphumo zempilo eziphuculweyo.
Ngokungeniswa kweRaloxifene Hydrochloride kwindawo yokhathalelo lwempilo, izigulane ezijongene ne-osteoporosis, umhlaza webele, kunye nezinye iimeko zempilo ezinxulumene nazo zinokujonga phambili kwikamva eliqaqambileyo.Amandla ayo angenakulinganiswa, akhululekile kwimiphumo emibi ye-estrogen, iphawula inyathelo elibalulekileyo eliya phambili ekufuneni unyango olusebenzayo, olukhuselekileyo, noluphezulu.Njengoko eli yeza liphumeleleyo liqhubeka nokuhlengahlengisa iindlela zokhathalelo lwempilo, iingcali zilindele impembelelo yenguqu kubomi babantu abaninzi kwihlabathi liphela.
Ukuziphendulela: Eli nqaku lenzelwe iinjongo zolwazi kuphela kwaye akufanele lithathwe njengengcebiso yezonyango.Abafundi kufuneka badibane nengcali yezempilo phambi kokuba baqalise naliphi na iyeza elitsha okanye irejimeni yonyango.
Ixesha lokuposa: Jul-08-2023